In today’s session AmerisourceBergen Corp. (ABC) recorded an unusually high (400) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious ABC decrease. With 400 contracts traded and 2164 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: ABC161118P00080000 closed last at: $2.85 or 1.7% down. About 335,510 shares traded hands. AmerisourceBergen Corp. (NYSE:ABC) has declined 9.89% since March 7, 2016 and is downtrending. It has underperformed by 17.48% the S&P500.
Analysts await AmerisourceBergen Corp. (NYSE:ABC) to report earnings on November, 3. They expect $1.24 EPS, up 5.98% or $0.07 from last year’s $1.17 per share. ABC’s profit will be $292.25M for 16.06 P/E if the $1.24 EPS becomes a reality. After $1.37 actual EPS reported by AmerisourceBergen Corp. for the previous quarter, Wall Street now forecasts -9.49% negative EPS growth.
AmerisourceBergen Corp. (NYSE:ABC) Ratings Coverage
Out of 15 analysts covering AmerisourceBergen (NYSE:ABC), 6 rate it a “Buy”, 1 “Sell”, while 8 “Hold”. This means 40% are positive. $130 is the highest target while $84 is the lowest. The $99.77 average target is 25.28% above today’s ($79.64) stock price. AmerisourceBergen has been the topic of 27 analyst reports since July 27, 2015 according to StockzIntelligence Inc. On Thursday, February 4 the stock rating was maintained by FBR Capital with “Mkt Perform”. Raymond James downgraded the shares of ABC in a report on Wednesday, January 6 to “Market Perform” rating. FBR Capital maintained the shares of ABC in a report on Friday, May 6 with “Mkt Perform” rating. Credit Suisse maintained AmerisourceBergen Corp. (NYSE:ABC) rating on Tuesday, November 17. Credit Suisse has “Outperform” rating and $121 price target. On Tuesday, October 4 the stock rating was upgraded by Avondale to “Mkt Outperform”. Morgan Stanley downgraded the shares of ABC in a report on Friday, October 2 to “Underweight” rating. The stock of AmerisourceBergen Corp. (NYSE:ABC) earned “Buy” rating by UBS on Friday, February 5. The company was maintained on Wednesday, October 7 by RBC Capital Markets. The company was upgraded on Tuesday, August 25 by Zacks. The rating was maintained by Mizuho with “Neutral” on Wednesday, November 18.
According to Zacks Investment Research, “AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.”
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The company has a market cap of $18.77 billion. The Firm operates through two divisions: Pharmaceutical Distribution and Other. It has a 10.74 P/E ratio. The Firm also provides data and other services to its manufacturing customers.
ABC Company Profile
AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Firm operates through two divisions: Pharmaceutical Distribution and Other. The Firm provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Firm provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Firm also provides data and other services to its manufacturing customers. The Firm has a distribution facility network totaling approximately 30 distribution facilities in the United States. The Company’s services for manufacturers include assistance with product launches, promotional and marketing services to accelerate product sales, product data reporting and logistical support. The Firm is a well-known provider of solutions, including the Good Neighbor Pharmacy program, which enables independent community pharmacies; Elevate Provider Network, a managed care network, which connects the retail pharmacy clients to payor plans throughout the country; generic product purchasing and private label services; hospital pharmacy consulting, and packaging solutions for institutional and retail healthcare providers.
More news for AmerisourceBergen Corp. (NYSE:ABC) were recently published by: Reuters.com, which released: “BRIEF-Amerisourcebergen corp president, CEO, steven collis, adopted 10b5-1…” on September 19, 2016. Moodys.com‘s article titled: “Moody’s changes AmerisourceBergen’s outlook to stable; affirms Baa2” and published on October 07, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.